Moreover, expression of the immune inhibitory checkpoint receptor CTLA-4 (CD152) was significantly increased in tumor compared to normal epithelium (Log2 fold-change = 0.7106, P-value = 0.013) (Figure 2I). This evidence concerns the gene CTLA4 and neoplasm.